ArticleInternal and emergency medicine2025
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Pre-ablation rate control therapy and direct-to-catheter ablation in patients with persistent atrial fibrillation: A DECAAF II subanalysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Article
- Before atrial fibrillation is attributed to e-cigarettes, alternative triggers must be thoroughly ruled out.Journal of Taibah University Medical Sciences · 2026Article
- Risks of discontinuation of anticoagulation after atrial fibrillation ablation in high-risk patients.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- Integrating preoperative multiregion radiomic features with clinical data to predict atrial fibrillation recurrence after radiofrequency ablation.Frontiers in cardiovascular medicine · 2026Article
- CHAFrontiers in cardiovascular medicine · 2026Article
- Application of Artificial Intelligence in the Early Detection and Management of Atrial Fibrillation: State-of-the-art Review.European cardiology · 2026Review
- The interactive effect of sex and neutrophil-to-lymphocyte ratio on short-term poor outcomes in patients with nonvalvular atrial fibrillation-related acute cardioembolic stroke.European journal of medical research · 2025Article
- Apixaban in subclinical atrial fibrillation: stroke-driven value amid economic uncertainty.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Article
- From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025Article
- International expert consensus on a structured approach to training for cryoballoon-based ablation for atrial fibrillation procedure using performance metrics.European heart journal open · 2025Article
- Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes.Journal of cardiovascular development and disease · 2025Article
- The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice.Internal and emergency medicine · 2025Article
- Prediction of the impact of anxiety on atrial fibrillation recurrence after radiofrequency catheter ablation based on heart rate variability.Frontiers in surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, and it is associated with substantial morbidity, mortality, and economic burden. Effective management of AF remains a critical focus in contemporary medicine, given its complex and multifaceted nature. In the present paper, we provide the essential updates for everyday clinical practice from the 2024 European Society of Cardiology (ESC) guidelines for AF management. We highlight seven key areas encompassing the adoption of the CHA₂DS₂-VA score for thromboembolic risk stratification, changes in bleeding risk assessment, expanded indications for catheter ablation, promotion of the multidisciplinary AF-CARE pathway for patient management, new recommendations for left atrial appendage closure, updates on clinical decision-making for atrial high-rate episodes, and considerations on the future role of artificial intelligence in advancing predictive analytics. We also compare the new recommendations proposed by the ESC 2024 AF guidelines with the ESC 2021 edition and the 2023 guidelines published by the American College of Cardiology/American Heart Association (ACC/AHA), reflecting regional perspectives and advancements in the field. By presenting these practical updates and their implications for routine practice, this paper aims to guide clinicians in adopting the latest evidence-based approaches to optimize AF patients' care.
Indexed as
Identifiers
40514614What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.